Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes

被引：0
|
作者：
Keiichi Torimoto
Yosuke Okada
Hiroko Mori
Maiko Hajime
Kenichi Tanaka
Akira Kurozumi
Manabu Narisawa
Sunao Yamamoto
Tadashi Arao
Hirofumi Matsuoka
Nobuo Inokuchi
Yoshiya Tanaka
机构：
[1] University of Occupational and Environmental Health,First Department of Internal Medicine, School of Medicine
[2] 1-1 Iseigaoka,undefined
[3] Matsuoka Clinic,undefined
[4] Inokuchi Clinic,undefined
来源：
Lipids in Health and Disease | / 12卷
关键词：
Rosuvastatin; Ezetimibe; Hypercholesterolemia; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study
    Ling, Paul Kah Hing
    Civeira, Fernando
    Dan, Andrei Gheorghe
    Hanson, Mary E.
    Massaad, Rachid
    De Tilleghem, Celine Le Bailly
    Milardo, Christopher
    Triscari, Joseph
    LIPIDS IN HEALTH AND DISEASE, 2012, 11
  • [42] Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia
    Durrington, PN
    Tuomilehto, J
    Hamann, A
    Kallend, D
    Smith, K
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 64 (02) : 137 - 151
  • [43] Effect of rosuvastatin 5-20 mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia
    Saito, Yasushi
    Yamada, Nobuhiro
    Shirai, Kohji
    Sasaki, Jun
    Ebihara, Yoshinori
    Yanase, Toshihiko
    Fox, Jonathan C.
    ATHEROSCLEROSIS, 2007, 194 (02) : 505 - 511
  • [44] Comparison of the Effects of Combination Atorvastatin (40 mg) + Ezetimibe (10 mg) Versus Atorvastatin (40 mg) Alone on Secretory Phospholipase A2 Activity in Patients With Stable Coronary Artery Disease or Coronary Artery Disease Equivalent
    Azar, Mireille
    Valentin, Emmanuel
    Badaoui, Georges
    Kassab, Roland
    Sarkis, Antoine
    Azar, Rabih R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (11) : 1571 - 1574
  • [45] COMPARATIVE EFFICACY AND TOLERABILITY OF 5 AND 10 MG SIMVASTATIN AND 10 MG PRAVASTATIN IN MODERATE PRIMARY HYPERCHOLESTEROLEMIA - SIMVASTATIN PRAVASTATIN EUROPEAN STUDY-GROUP
    STEINHAGENTHIESSEN, E
    CARDIOLOGY, 1994, 85 (3-4) : 244 - 254
  • [46] Rosuvastatin Increased Serum Osteocalcin Levels Independent of Its Serum Cholesterol-Lowering Effect in Patients with Type 2 Diabetes and Hypercholesterolemia
    Kanazawa, Ippei
    Yamaguchi, Toru
    Yamauchi, Mika
    Sugimoto, Toshitsugu
    INTERNAL MEDICINE, 2009, 48 (21) : 1869 - 1873
  • [47] Effects of rosuvastatin/ezetimibe on senescence of CD8+T-cell in type 2 diabetic patients with hypercholesterolemia: A study protocol
    Ju, Sang Hyeon
    Ku, Bon Jeong
    MEDICINE, 2022, 101 (47) : E31691
  • [48] Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial
    Amedeo Vattimo, Antonio Carlos
    Helfestein Fonseca, Francisco Antonio
    Morais, Douglas Costa
    Generoso, Larissa Fontes
    Herrera, Renata
    Barbosa, Cristiane Moraes
    de Oliveira Izar, Maria Cristina
    Cardoso, Rita Antonelli
    Zung, Stevin
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 93
  • [49] ODYSSEY MONO: effect of alirocumab 75 mg subcutaneously every 2 weeks as monotherapy versus ezetimibe over 24 weeks
    Roth, Eli M.
    McKenney, James M.
    FUTURE CARDIOLOGY, 2015, 11 (01) : 27 - 37
  • [50] Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
    Ju, Sang-Hyeon
    Lim, Joung Youl
    Song, Minchul
    Kim, Ji Min
    Kang, Yea Eun
    Yi, Hyon-Seung
    Joung, Kyong Hye
    Lee, Ju Hee
    Kim, Hyun Jin
    Ku, Bon Jeong
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345